ESMO Open Journal Citation Rate 2026
2059-7029
Elsevier BV
NL
Q2 Quartile Open Access
About ESMO Open
ESMO Open (EO) is a peer-reviewed academic journal covering Advanced Breast Cancer Therapies and Breast Cancer Treatment Studies, published by Elsevier BV in NL, catalogued under ISSN 2059-7029. As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.45 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $2965 USD. OpenAlex records 8,328 works and 55,191 citations, with an h-index of 97.
ESMO Open Citation Rate 2026 — In Context
ESMO Open has a 2025 2-Year Citation Rate (OpenAlex) of 1.45, placing it in the Q2 quartile within the Advanced Breast Cancer Therapies research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
As a fully open-access publication, ESMO Open makes all articles freely available to readers for an Article Processing Charge of approximately $2965 USD.
Researchers looking to publish in ESMO Open should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare ESMO Open against similar journals in the field, use our journal comparison tool.
Submission Tips for ESMO Open
- Budget $2965 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Cancer Immunotherapy and Biomarkers. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How ESMO Open Compares
Compared against 32 journals in the same research areas.
| ISSN (Print) | 2059-7029 |
|---|---|
| Publisher | Elsevier BV |
| Country | Netherlands |
| APC / Cost | $2965 USD |
In-depth profile & metrics
ESMO Open is published by Elsevier BV and based in Netherlands. It publishes open access with an article-processing charge of USD 2965.
In our subject taxonomy, ESMO Open is classified under Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Cancer Immunotherapy and Biomarkers and HER2/EGFR in Cancer Research.
ESMO Open is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 1.453.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about ESMO Open
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 1.453 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare ESMO Open against similar publications in its field:
Related Journals in Your Field
-
Cancer Cell Elsevier IF 64.50
-
Journal for ImmunoTherapy of Cancer BMJ IF 7.57
-
Journal of Translational Medicine BioMed Central IF 6.81
-
Cancer Immunology Immunotherapy Springer Science+Business Media IF 4.62
-
Critical Reviews in Oncology/Hematology Elsevier BV IF 4.62
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S4210217024
Get weekly updates for Advanced Breast Cancer Therapies journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.